Cartesian Therapeutics Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +187.7% | +6.6% | +6.9% | +30.9% | -4.5% | -6.0% | -4.9% | -4.2% | -20.5% | -2.7% | +10.5% | |
| – | +1.0% | +22.5% | +12.3% | +83.6% | -5.5% | -14.5% | -11.7% | -9.9% | -12.2% | -5.6% | +25.9% | |
| – | -3.4% | +34.5% | -15.7% | +151.3% | -3.0% | -15.1% | -11.1% | -10.6% | -12.7% | -5.2% | +24.4% | |
| – | -3.4% | +34.5% | -15.7% | +151.3% | -3.0% | -15.1% | -11.1% | -10.6% | -12.7% | -5.2% | +24.4% | |
| – | +30.7% | -50.6% | +711.5% | -83.6% | -85.0% | +102.4% | -79.9% | +104.0% | +54.4% | -76.6% | -24.9% | |
| – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -37.6% | +0.0% | +0.0% | |
| – | +1,530.5% | -40.7% | +1.6% | +1.2% | -2.8% | -2.5% | -9.2% | +4.4% | +3.5% | +3.3% | +1.7% | |
| – | +242.1% | -46.3% | -28.8% | -18.0% | +7.3% | -34.7% | -18.3% | +12.6% | +8.2% | +6.7% | +28.9% | |
| – | +21.2% | +2.9% | +13.2% | +9.8% | +2.9% | +29.9% | +2.3% | +2.3% | +7.1% | +0.8% | +0.3% | |
| – | +740.0% | -20.1% | +13.7% | -81.9% | -44.3% | +628.1% | -78.4% | +390.1% | -42.1% | +24.1% | -34.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -829.6% | – | – | – | -1,004.5% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +4.7% | +228.6% | +20.7% | +20.7% | 0.0% | +2.1% | -1.7% | -0.1% | +3.4% | +11.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.